Industry Research Reports
Home > Reports > Service & Software > AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-07-14
Pages: 108 Pages
Report ld: 6915398
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
This report provides a comprehensive view of the global market for AI-enabled Imaging Modality, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The AI-enabled Imaging Modality market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding AI-enabled Imaging Modality.
MARKET SEGMENTATION
By Company
- Koninklijke Philips N.V.
- Siemens Healthineers AG.
- General Electric Company
- Canon
- Hologic
- Butterfly Network
- Hyperfine
- United Health Imaging
- Yorlabs
- Nanox
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Computed Tomography
- MRI
- X-Ray
- Ultrasound
- Positron Emission Tomography
- Others
Segment by Application
- Hospital
- Cilinic
- Labs
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the AI-enabled Imaging Modality companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents AI-enabled Imaging Modality revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents AI-enabled Imaging Modality revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 AI-enabled Imaging Modality Product Introduction
1.2 Global AI-enabled Imaging Modality Market Size Forecast (2021–2032)
1.3 AI-enabled Imaging Modality Market Trends & Drivers
1.3.1 AI-enabled Imaging Modality Industry Trends
1.3.2 AI-enabled Imaging Modality Market Drivers & Opportunities
1.3.3 AI-enabled Imaging Modality Market Challenges
1.3.4 AI-enabled Imaging Modality Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI-enabled Imaging Modality Players Revenue Ranking (2025)
2.2 Global AI-enabled Imaging Modality Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies AI-enabled Imaging Modality Product Offerings
2.5 Key Companies General Availability (GA) Timeline for AI-enabled Imaging Modality
2.6 AI-enabled Imaging Modality Market Competitive Analysis
2.6.1 AI-enabled Imaging Modality Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by AI-enabled Imaging Modality Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on AI-enabled Imaging Modality revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation AI-enabled Imaging Modality Market Classification
3.1 Introduction by Type
3.1.1 Computed Tomography
3.1.2 MRI
3.1.3 X-Ray
3.1.4 Ultrasound
3.1.5 Positron Emission Tomography
3.1.6 Others
3.1.7 Global AI-enabled Imaging Modality Sales Value by Type
3.1.7.1 Global AI-enabled Imaging Modality Sales Value by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global AI-enabled Imaging Modality Sales Value, by Type (2021–2032)
3.1.7.3 Global AI-enabled Imaging Modality Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Cilinic
4.1.3 Labs
4.2 Global AI-enabled Imaging Modality Sales Value by Application
4.2.1 Global AI-enabled Imaging Modality Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global AI-enabled Imaging Modality Sales Value by Application (2021–2032)
4.2.3 Global AI-enabled Imaging Modality Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global AI-enabled Imaging Modality Sales Value by Region
5.1.1 Global AI-enabled Imaging Modality Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global AI-enabled Imaging Modality Sales Value by Region (2021–2026)
5.1.3 Global AI-enabled Imaging Modality Sales Value by Region (2027–2032)
5.1.4 Global AI-enabled Imaging Modality Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America AI-enabled Imaging Modality Sales Value, 2021–2032
5.2.2 North America AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe AI-enabled Imaging Modality Sales Value, 2021–2032
5.3.2 Europe AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific AI-enabled Imaging Modality Sales Value, 2021–2032
5.4.2 Asia Pacific AI-enabled Imaging Modality Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America AI-enabled Imaging Modality Sales Value, 2021–2032
5.5.2 South America AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI-enabled Imaging Modality Sales Value, 2021–2032
5.6.2 Middle East & Africa AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI-enabled Imaging Modality Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions AI-enabled Imaging Modality Sales Value, 2021–2032
6.3 United States
6.3.1 United States AI-enabled Imaging Modality Sales Value, 2021–2032
6.3.2 United States AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.3.3 United States AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe AI-enabled Imaging Modality Sales Value, 2021–2032
6.4.2 Europe AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China AI-enabled Imaging Modality Sales Value, 2021–2032
6.5.2 China AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.5.3 China AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan AI-enabled Imaging Modality Sales Value, 2021–2032
6.6.2 Japan AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea AI-enabled Imaging Modality Sales Value, 2021–2032
6.7.2 South Korea AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia AI-enabled Imaging Modality Sales Value, 2021–2032
6.8.2 Southeast Asia AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India AI-enabled Imaging Modality Sales Value, 2021–2032
6.9.2 India AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
6.9.3 India AI-enabled Imaging Modality Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Koninklijke Philips N.V.
7.1.1 Koninklijke Philips N.V. Profile
7.1.2 Koninklijke Philips N.V. Main Business
7.1.3 Koninklijke Philips N.V. AI-enabled Imaging Modality Products, Services, and Solutions
7.1.4 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.1.5 Koninklijke Philips N.V. Recent Developments
7.2 Siemens Healthineers AG.
7.2.1 Siemens Healthineers AG. Profile
7.2.2 Siemens Healthineers AG. Main Business
7.2.3 Siemens Healthineers AG. AI-enabled Imaging Modality Products, Services, and Solutions
7.2.4 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.2.5 Siemens Healthineers AG. Recent Developments
7.3 General Electric Company
7.3.1 General Electric Company Profile
7.3.2 General Electric Company Main Business
7.3.3 General Electric Company AI-enabled Imaging Modality Products, Services, and Solutions
7.3.4 General Electric Company AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.3.5 General Electric Company Recent Developments
7.4 Canon
7.4.1 Canon Profile
7.4.2 Canon Main Business
7.4.3 Canon AI-enabled Imaging Modality Products, Services, and Solutions
7.4.4 Canon AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.4.5 Canon Recent Developments
7.5 Hologic
7.5.1 Hologic Profile
7.5.2 Hologic Main Business
7.5.3 Hologic AI-enabled Imaging Modality Products, Services, and Solutions
7.5.4 Hologic AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.5.5 Hologic Recent Developments
7.6 Butterfly Network
7.6.1 Butterfly Network Profile
7.6.2 Butterfly Network Main Business
7.6.3 Butterfly Network AI-enabled Imaging Modality Products, Services, and Solutions
7.6.4 Butterfly Network AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.6.5 Butterfly Network Recent Developments
7.7 Hyperfine
7.7.1 Hyperfine Profile
7.7.2 Hyperfine Main Business
7.7.3 Hyperfine AI-enabled Imaging Modality Products, Services, and Solutions
7.7.4 Hyperfine AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.7.5 Hyperfine Recent Developments
7.8 United Health Imaging
7.8.1 United Health Imaging Profile
7.8.2 United Health Imaging Main Business
7.8.3 United Health Imaging AI-enabled Imaging Modality Products, Services, and Solutions
7.8.4 United Health Imaging AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.8.5 United Health Imaging Recent Developments
7.9 Yorlabs
7.9.1 Yorlabs Profile
7.9.2 Yorlabs Main Business
7.9.3 Yorlabs AI-enabled Imaging Modality Products, Services, and Solutions
7.9.4 Yorlabs AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.9.5 Yorlabs Recent Developments
7.10 Nanox
7.10.1 Nanox Profile
7.10.2 Nanox Main Business
7.10.3 Nanox AI-enabled Imaging Modality Products, Services, and Solutions
7.10.4 Nanox AI-enabled Imaging Modality Revenue (US$ Million), 2021–2026
7.10.5 Nanox Recent Developments
8 Industry Chain Analysis
8.1 AI-enabled Imaging Modality Value Chain
8.2 AI-enabled Imaging Modality Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 AI-enabled Imaging Modality Sales Model
8.5.2 Sales Channels
8.5.3 AI-enabled Imaging Modality Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. AI-enabled Imaging Modality Market Trends
Table 2. AI-enabled Imaging Modality Market Drivers & Opportunities
Table 3. AI-enabled Imaging Modality Market Challenges
Table 4. AI-enabled Imaging Modality Market Restraints
Table 5. Global AI-enabled Imaging Modality Revenue by Company (US$ Million), 2021–2026
Table 6. Global AI-enabled Imaging Modality Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies AI-enabled Imaging Modality Product Type
Table 9. Key Companies General Availability (GA) Timeline for AI-enabled Imaging Modality
Table 10. Global AI-enabled Imaging Modality Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on AI-enabled Imaging Modality revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global AI-enabled Imaging Modality Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global AI-enabled Imaging Modality Sales Value by Type (US$ Million), 2021–2026
Table 15. Global AI-enabled Imaging Modality Sales Value by Type (US$ Million), 2027–2032
Table 16. Global AI-enabled Imaging Modality Sales Market Share in Value by Type (2021–2026)
Table 17. Global AI-enabled Imaging Modality Sales Market Share in Value by Type (2027–2032)
Table 18. Global AI-enabled Imaging Modality Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global AI-enabled Imaging Modality Sales Value by Application (US$ Million), 2021–2026
Table 20. Global AI-enabled Imaging Modality Sales Value by Application (US$ Million), 2027–2032
Table 21. Global AI-enabled Imaging Modality Sales Market Share in Value by Application (2021–2026)
Table 22. Global AI-enabled Imaging Modality Sales Market Share in Value by Application (2027–2032)
Table 23. Global AI-enabled Imaging Modality Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global AI-enabled Imaging Modality Sales Value by Region (US$ Million), 2021–2026
Table 25. Global AI-enabled Imaging Modality Sales Value by Region (US$ Million), 2027–2032
Table 26. Global AI-enabled Imaging Modality Sales Value by Region (%), 2021–2026
Table 27. Global AI-enabled Imaging Modality Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions AI-enabled Imaging Modality Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions AI-enabled Imaging Modality Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions AI-enabled Imaging Modality Sales Value, (US$ Million), 2027–2032
Table 31. Koninklijke Philips N.V. Basic Information List
Table 32. Koninklijke Philips N.V. Description and Business Overview
Table 33. Koninklijke Philips N.V. AI-enabled Imaging Modality Products, Services, and Solutions
Table 34. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Koninklijke Philips N.V. (2021–2026)
Table 35. Koninklijke Philips N.V. Recent Developments
Table 36. Siemens Healthineers AG. Basic Information List
Table 37. Siemens Healthineers AG. Description and Business Overview
Table 38. Siemens Healthineers AG. AI-enabled Imaging Modality Products, Services, and Solutions
Table 39. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Siemens Healthineers AG. (2021–2026)
Table 40. Siemens Healthineers AG. Recent Developments
Table 41. General Electric Company Basic Information List
Table 42. General Electric Company Description and Business Overview
Table 43. General Electric Company AI-enabled Imaging Modality Products, Services, and Solutions
Table 44. Revenue (US$ Million) in AI-enabled Imaging Modality Business of General Electric Company (2021–2026)
Table 45. General Electric Company Recent Developments
Table 46. Canon Basic Information List
Table 47. Canon Description and Business Overview
Table 48. Canon AI-enabled Imaging Modality Products, Services, and Solutions
Table 49. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Canon (2021–2026)
Table 50. Canon Recent Developments
Table 51. Hologic Basic Information List
Table 52. Hologic Description and Business Overview
Table 53. Hologic AI-enabled Imaging Modality Products, Services, and Solutions
Table 54. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Hologic (2021–2026)
Table 55. Hologic Recent Developments
Table 56. Butterfly Network Basic Information List
Table 57. Butterfly Network Description and Business Overview
Table 58. Butterfly Network AI-enabled Imaging Modality Products, Services, and Solutions
Table 59. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Butterfly Network (2021–2026)
Table 60. Butterfly Network Recent Developments
Table 61. Hyperfine Basic Information List
Table 62. Hyperfine Description and Business Overview
Table 63. Hyperfine AI-enabled Imaging Modality Products, Services, and Solutions
Table 64. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Hyperfine (2021–2026)
Table 65. Hyperfine Recent Developments
Table 66. United Health Imaging Basic Information List
Table 67. United Health Imaging Description and Business Overview
Table 68. United Health Imaging AI-enabled Imaging Modality Products, Services, and Solutions
Table 69. Revenue (US$ Million) in AI-enabled Imaging Modality Business of United Health Imaging (2021–2026)
Table 70. United Health Imaging Recent Developments
Table 71. Yorlabs Basic Information List
Table 72. Yorlabs Description and Business Overview
Table 73. Yorlabs AI-enabled Imaging Modality Products, Services, and Solutions
Table 74. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Yorlabs (2021–2026)
Table 75. Yorlabs Recent Developments
Table 76. Nanox Basic Information List
Table 77. Nanox Description and Business Overview
Table 78. Nanox AI-enabled Imaging Modality Products, Services, and Solutions
Table 79. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Nanox (2021–2026)
Table 80. Nanox Recent Developments
Table 81. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Company 40 (2021–2026)
Table 82. Company 40 Recent Developments
Table 83. Key Raw Materials Lists
Table 84. Key Suppliers of Raw Materials Lists
Table 85. AI-enabled Imaging Modality Downstream Customers
Table 86. AI-enabled Imaging Modality Distributors List
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. AI-enabled Imaging Modality Product Picture
Figure 2. Global AI-enabled Imaging Modality Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 4. AI-enabled Imaging Modality Report Years Considered
Figure 5. Global AI-enabled Imaging Modality Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI-enabled Imaging Modality Revenue in 2025
Figure 7. AI-enabled Imaging Modality Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Computed Tomography Picture
Figure 9. MRI Picture
Figure 10. X-Ray Picture
Figure 11. Ultrasound Picture
Figure 12. Positron Emission Tomography Picture
Figure 13. Others Picture
Figure 14. Global AI-enabled Imaging Modality Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global AI-enabled Imaging Modality Sales Value Market Share by Type, 2025 & 2032
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Cilinic
Figure 18. Product Picture of Labs
Figure 19. Global AI-enabled Imaging Modality Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global AI-enabled Imaging Modality Sales Value Market Share by Application, 2025 & 2032
Figure 21. North America AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 22. North America AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
Figure 23. Europe AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 24. Europe AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
Figure 25. Asia Pacific AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 26. Asia Pacific AI-enabled Imaging Modality Sales Value by Subregion (%), 2025 vs 2032
Figure 27. South America AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 28. South America AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
Figure 29. Middle East & Africa AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 30. Middle East & Africa AI-enabled Imaging Modality Sales Value by Country (%), 2025 vs 2032
Figure 31. Key Countries/Regions AI-enabled Imaging Modality Sales Value (%), 2021–2032
Figure 32. United States AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 33. United States AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 34. United States AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 35. Europe AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 36. Europe AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 37. Europe AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 38. China AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 39. China AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 40. China AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 41. Japan AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 42. Japan AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 43. Japan AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 44. South Korea AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 45. South Korea AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 46. South Korea AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 47. Southeast Asia AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 48. Southeast Asia AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 49. Southeast Asia AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 50. India AI-enabled Imaging Modality Sales Value (US$ Million), 2021–2032
Figure 51. India AI-enabled Imaging Modality Sales Value by Type (%), 2025 vs 2032
Figure 52. India AI-enabled Imaging Modality Sales Value by Application (%), 2025 vs 2032
Figure 53. AI-enabled Imaging Modality Value Chain
Figure 54. AI-enabled Imaging Modality Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global AI-enabled Imaging Modality market?
The top companies in the global AI-enabled Imaging Modality market are Koninklijke Philips N.V.、Siemens Healthineers AG.、General Electric Company.
Related Reports
Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 104
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-enabled Imaging Modality market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 123
USD 4900.00
(Single User License)
Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 78
USD 4250.00
(Single User License)
AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 81
USD 3950.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 77
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-02-06
Pages: 87
USD 2900.00
(Single User License)
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-01-12
Pages: 112
USD 3950.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 104
USD 2900.00 (Single User License)Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-enabled Imaging Modality market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 123
USD 4900.00 (Single User License)Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 78
USD 4250.00 (Single User License)AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 81
USD 3950.00 (Single User License)Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 77
USD 2900.00 (Single User License)Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-04-26
Pages: 112
USD 4900.00 (Single User License)Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-02-06
Pages: 87
USD 2900.00 (Single User License)AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-01-12
Pages: 112
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now